Potassium paraaminobenzoate vs placebo
Treatment discontinuation · men with acute (maximum of 12 months) Peyronie's disease with no prior treatment and no evidence of calcified plaques (pain during…
It is very uncertain whether potassium paraaminobenzoate changes discontinuation from treatment compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.36 [0.72, 2.58]1 study · 103 participantsVery low